SUNPHARMA.NSSUNPHARMA.NSNSE
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank82
3Y CAGR+39.8%
5Y CAGR+16.8%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+39.8%/yr
Quarterly compound
5Y CAGR
+16.8%/yr
Recent acceleration
Percentile
P82
Within normal range
vs 5Y Ago
2.2x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 7.20% |
| Q3 2025 | 4.53% |
| Q2 2025 | 6.89% |
| Q1 2025 | -5.24% |
| Q4 2024 | 2.89% |
| Q3 2024 | 5.05% |
| Q2 2024 | 5.59% |
| Q1 2024 | -3.21% |
| Q4 2023 | 1.54% |
| Q3 2023 | 2.11% |
| Q2 2023 | 9.24% |
| Q1 2023 | -2.76% |
| Q4 2022 | 2.64% |
| Q3 2022 | 1.77% |
| Q2 2022 | 13.92% |
| Q1 2022 | -4.22% |
| Q4 2021 | 2.46% |
| Q3 2021 | -0.95% |
| Q2 2021 | 14.03% |
| Q1 2021 | -3.55% |
| Q4 2020 | 3.32% |
| Q3 2020 | 12.76% |
| Q2 2020 | -7.33% |
| Q1 2020 | 0.37% |
| Q4 2019 | 0.39% |
| Q3 2019 | -3.00% |
| Q2 2019 | 16.90% |
| Q1 2019 | -7.45% |
| Q4 2018 | 11.57% |
| Q3 2018 | -3.97% |
| Q2 2018 | 4.65% |
| Q1 2018 | 3.76% |
| Q4 2017 | 0.04% |
| Q3 2017 | 7.11% |
| Q2 2017 | -10.05% |
| Q1 2017 | -12.77% |
| Q4 2016 | -4.26% |
| Q3 2016 | 0.27% |
| Q2 2016 | 6.60% |
| Q1 2016 | 9.74% |